Analyst Information

RedHill Biopharma Ltd is covered by the following analysts.

Firm Analyst
Ladenburg Thalmann
Matthew L. Kaplan
Robert Hazlett
SMBC Nikko Securities America
David Hoang, MD, PhD
H.C. Wainwright & Co.
Raghuram (Ram) Selvaraju, Ph.D.
Roth Capital Partners
Scott Henry, CFA
Ascendiant Capital Markets
Edward Woo, CFA

RedHill Biopharma Ltd. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding RedHill Biopharma Ltd.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of RedHill Biopharma Ltd. or its management. RedHill Biopharma Ltd. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.